Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.
Title | Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. |
Publication Type | Journal Articles |
Year of Publication | 2011 |
Authors | Korpal M, Ell BJ, Buffa FM, Ibrahim T, Blanco MA, Celià-Terrassa T, Mercatali L, Khan Z, Goodarzi H, Hua Y, Wei Y, Hu G, Garcia BA, Ragoussis J, Amadori D, Harris AL, Kang Y |
Journal | Nat Med |
Volume | 17 |
Issue | 9 |
Pagination | 1101-8 |
Date Published | 2011 Sep |
ISSN | 1546-170X |
Keywords | Animals, Cadherins, Cell Line, Tumor, Female, Gene Expression Profiling, Gene Expression Regulation, Neoplastic, HUMANS, Mass Spectrometry, Mice, Mice, Inbred BALB C, Microarray Analysis, MicroRNAs, Neoplasm Metastasis, Statistics, Nonparametric, Vesicular Transport Proteins |
Abstract | Although the role of miR-200s in regulating E-cadherin expression and epithelial-to-mesenchymal transition is well established, their influence on metastatic colonization remains controversial. Here we have used clinical and experimental models of breast cancer metastasis to discover a pro-metastatic role of miR-200s that goes beyond their regulation of E-cadherin and epithelial phenotype. Overexpression of miR-200s is associated with increased risk of metastasis in breast cancer and promotes metastatic colonization in mouse models, phenotypes that cannot be recapitulated by E-cadherin expression alone. Genomic and proteomic analyses revealed global shifts in gene expression upon miR-200 overexpression toward that of highly metastatic cells. miR-200s promote metastatic colonization partly through direct targeting of Sec23a, which mediates secretion of metastasis-suppressive proteins, including Igfbp4 and Tinagl1, as validated by functional and clinical correlation studies. Overall, these findings suggest a pleiotropic role of miR-200s in promoting metastatic colonization by influencing E-cadherin-dependent epithelial traits and Sec23a-mediated tumor cell secretome. |
DOI | 10.1038/nm.2401 |
Alternate Journal | Nat. Med. |
PubMed ID | 21822286 |
PubMed Central ID | PMC3169707 |
Grant List | 090532 / / Wellcome Trust / United Kingdom 1R01-CA141062 / CA / NCI NIH HHS / United States R01 CA134519 / CA / NCI NIH HHS / United States R01 CA134519-04 / CA / NCI NIH HHS / United States R01 CA141062 / CA / NCI NIH HHS / United States R01 CA141062-01A1 / CA / NCI NIH HHS / United States R01 CA141062-02 / CA / NCI NIH HHS / United States R01 CA141062-03 / CA / NCI NIH HHS / United States / / Cancer Research UK / United Kingdom |